Related Experiment Video
Updated: Sep 17, 2025
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Deadly trends: Medicare Benefits Schedule nicotine and smoking cessation items, 2021-23
Daniel Bogale Odo1, Tanya Buchanan2, Megan Varlow3
1BSc, MPH, PhD, Research Fellow, National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, National Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT.
Background And Objectives:
Comprehensive nicotine and smoking cessation interventions can be crucial for successful and sustained cessation, but require adequate time, training and experience. This study aimed to quantify uptake of the temporary Medicare Benefits Schedule (MBS) smoking cessation services from July 2021 to December 2023.
Method:
MBS nicotine and smoking cessation claims processed for face-to-face and telehealth services from July 2021 to December 2023 were examined. Quarterly rates of claims and 95% confidence intervals per 1000 people who smoke were calculated.
Results:
Overall, 188,904 claims were processed during this period. The national trends in the rate of face-to-face (P<0.001) and telephone (P<0.001) services increased significantly. The quarterly rate of claims processed for face-to-face services increased by 16-fold, from a rate of 1 to 16 per 1000 people who smoke.
Discussion:
This study highlights that the temporary MBS smoking cessation services were increasingly used, but that changes to this service might deter smoking cessation efforts.
More Related Videos
06:07Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
01:23Inhaled Medications
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:29Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:20Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
01:17Drug Dependence